Skip to main content
. 2014 May 9;9(5):e95419. doi: 10.1371/journal.pone.0095419

Table 2. Study population.

A B C D E
HSD VALORE p HSD VALORE p HSD VALORE p HSD VALORE p HSD VALORE p
General population N GP 50 140 38 619 28 484 17 56 57 202
N population 67314 156516 54384 757163 34666 447577 23439 55992 75299 220843
N registered per GP 1346.3 1118.0 <0.001 1431.2 1223.2 <0.001 1238.1 924.7 Inline graphic0.001 1378.8 999.9 Inline graphic0.001 1321.0 1093.3 Inline graphic0.001
Female 52.7 54.5 <0.001 53.6 51.4 <0.001 52.5 54.2 Inline graphic0.001 51.1 52.0 Inline graphic0.05 52.8 50.9 Inline graphic0.001
Ageband 16–44 42.7 37.9 <0.001 37.4 42.3 <0.001 38.8 33.4 Inline graphic0.001 43.5 35.6 Inline graphic0.001 47.7 43.7 Inline graphic0.001
45–64 32.4 34.5 32.4 31.5 32.4 35.6 31.7 33.9 30.9 32.2
65–74 13.0 14.2 14.7 12.9 14.2 15.9 11.8 15.0 10.9 12.4
75–84 8.8 9.8 11.1 9.6 10.7 11.4 9.4 11.4 8.0 8.9
85–95 3.0 3.6 4.3 3.7 4.0 3.8 3.7 4.1 2.4 2.8
Diabetes N GP 50 137 38 619 28 484 17 56 57 202
N patients 4986 9122 4085 39138 2577 28872 1793 3132 7095 16490
N registered per GP 99.7 66.6 <0.001 107.5 63.2 <0.001 92.0 59.7 Inline graphic0.001 105.5 55.9 Inline graphic0.001 124.5 81.6 Inline graphic0.001
Female 45.2 46.7 0.089 46.0 47.1 0.193 48.3 49.3 0.313 46.4 47.5 0.454 51.4 50.8 0.388
Ageband 16–44 5.2 6.4 <0.001 3.6 5.7 <0.001 4.0 5.2 Inline graphic0.001 5.6 5.2 Inline graphic0.05 7.0 4.3 Inline graphic0.001
45–64 32.0 25.5 29.2 27.3 31.8 26.6 31.7 26.8 37.0 30.5
65–74 32.3 30.4 31.4 28.7 30.4 30.1 28.7 29.7 27.9 29.9
75–84 22.8 27.2 26.9 27.1 25.9 28.5 24.7 27.6 22.7 26.9
85–95 7.7 10.6 8.9 11.2 7.9 9.6 9.4 10.8 5.5 8.4
IHD N GP 50 137 38 619 28 484 17 56 57 201
N patients 2538 6041 2985 38324 1584 19366 1070 2622 3581 9782
N registered per GP 50.8 44.1 <0.05 78.6 61.9 <0.001 56.6 40.0 Inline graphic0.001 62.9 46.8 Inline graphic0.001 62.8 48.7 Inline graphic0.001
Female 38.1 41.9 <0.05 40.4 45.2 <0.001 39.4 42.0 Inline graphic0.05 40.7 39.9 0.669 39.6 40.0 0.657
Ageband 16–44 2.2 1.1 <0.001 1.1 1.1 <0.001 1.1 0.9 Inline graphic0.001 1.3 1.1 Inline graphic0.001 3.2 1.8 Inline graphic0.001
45–64 22.5 15.4 20.3 15.3 18.9 16.0 23.5 15.5 28.3 19.9
65–74 31.0 24.1 29.7 23.0 28.6 25.6 28.8 23.8 30.0 26.8
75–84 31.8 35.9 34.1 36.3 35.3 36.9 32.2 36.2 29.0 34.9
85–95 12.5 23.5 14.8 24.4 16.1 20.7 14.2 23.4 9.5 16.5
HF N GP 47 130 38 605 26 479 17 54 53 197
N patients 664 2110 842 12107 395 6577 296 692 726 2794
N registered per GP 14.1 16.2 0.080 22.2 20.0 0.150 15.2 13.7 0.229 17.4 12.8 Inline graphic0.05 13.7 14.2 0.642
Female 45.8 55.4 <0.001 56.3 51.8 <0.05 50.6 45.7 0.058 50.7 50.7 0.989 53.7 48.0 Inline graphic0.05
Ageband 16–44 0.5 0.7 <0.001 0.8 1.1 0.504 1.3 1.1 Inline graphic0.001 1.4 0.3 0.253 1.7 2.0 0.671
45–64 13.0 7.4 10.2 9.0 8.4 13.5 10.1 8.8 13.1 12.6
65–74 21.4 15.5 18.5 17.4 17.7 22.2 18.2 16.3 20.5 22.3
75–84 37.5 37.8 38.5 38.5 40.0 37.7 39.9 41.2 42.1 39.7
85–95 27.7 38.6 31.9 34.0 32.7 25.4 30.4 33.4 22.6 23.3

Description of the GPs in the five (A, B, C, D, E) pairs of samples (HS, measured by means of clinical data, and VALORE, measured by means of healthcare administrative data). Description of the general population they have in charge (general population), of diabetic patients (Diabetes), of patients with ischaemic heart disease (IHD) and of patients with heart failure (HF). N GP: number of GPs in the study. N populations: number of inhabitants registered with the GPs in the study. N patients: total number of patients with the chronic disease registered with GPs in the study. N registered per GP: average number of persons in charge to each GP, with test for difference in means within each pair. Female: percentage of women in the population, with test for difference in means within each pair. Age band: age distribution of the population, with chi square test within each pair.